FDA Clears PENS Device for Pain Related to Diabetic Peripheral Neuropathy
First Relief is a wearable PENS device that is placed behind the ear.
First Relief is a wearable PENS device that is placed behind the ear.
Presenting at AHS 2022, researchers examined the effects of supplementation of B vitamins and a combination of these vitamins on women with episodic migraine.
Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.
The Agency is currently seeking public comment on this potential modification to the existing Opioid Analgesic Risk Evaluation and Mitigation Strategy.
Authors outline the efficacy and safety of topical NSAIDs for the treatment of acute and chronic musculoskeletal pain conditions including osteoarthritis.
SP-102 is a dexamethasone sodium phosphate viscous gel formulation that is administered by epidural injection.
The PROGRESS study compared the efficacy and safety of atogepant to placebo in 778 adults with at least a 1-year history of chronic migraine.
Proposed changes dovetail with a nationwide epidemic of opioid use and overdose deaths.
Multimodal nonopioid regimen of NSAIDs and muscle relaxants provides similar or better pain control than opioids in ACL and rotator cuff surgeries.
Diffuse myofascial pain associated with fatigue and poor sleep hygiene have been noted in patients with long-COVID.